ArticleTheranostics2018

miR-125a-5p ameliorates hepatic glycolipid metabolism disorder in type 2 diabetes mellitus through targeting of STAT3.

Lina Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.